These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8035042)

  • 1. Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
    Cambau E; Sougakoff W; Besson M; Truffot-Pernot C; Grosset J; Jarlier V
    J Infect Dis; 1994 Aug; 170(2):479-83. PubMed ID: 8035042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria.
    Cambau E; Sougakoff W; Jarlier V
    FEMS Microbiol Lett; 1994 Feb; 116(1):49-54. PubMed ID: 8132154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones.
    Revel V; Cambau E; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1991-6. PubMed ID: 7811008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
    Arjomandzadegan M; Titov L; Farnia P; Owlia P; Ranjbar R; Sheikholeslami F; Surkova L
    Int J Mycobacteriol; 2016 Sep; 5(3):299-305. PubMed ID: 27847014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong.
    Williams KJ; Chan R; Piddock LJ
    J Antimicrob Chemother; 1996 May; 37(5):1032-4. PubMed ID: 8737156
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
    J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
    Cheng AF; Yew WW; Chan EW; Chin ML; Hui MM; Chan RC
    Antimicrob Agents Chemother; 2004 Feb; 48(2):596-601. PubMed ID: 14742214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients.
    Alangaden GJ; Manavathu EK; Vakulenko SB; Zvonok NM; Lerner SA
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1700-3. PubMed ID: 7486904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
    Sun Z; Zhang J; Zhang X; Wang S; Zhang Y; Li C
    Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
    Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
    Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
    Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.
    Tanaka M; Zhang YX; Ishida H; Akasaka T; Sato K; Hayakawa I
    J Med Microbiol; 1995 Mar; 42(3):214-9. PubMed ID: 7884804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
    Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
    J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.
    Cui Z; Wang J; Lu J; Huang X; Hu Z
    BMC Infect Dis; 2011 Mar; 11():78. PubMed ID: 21443804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates.
    Singh M; Jadaun GP; Ramdas ; Srivastava K; Chauhan V; Mishra R; Gupta K; Nair S; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    Indian J Med Res; 2011 May; 133(5):535-40. PubMed ID: 21623040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
    Yu X; Wang G; Chen S; Wei G; Shang Y; Dong L; Schön T; Moradigaravand D; Parkhill J; Peacock SJ; Köser CU; Huang H
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5232-7. PubMed ID: 27324769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India.
    Sulochana S; Narayanan S; Paramasivan CN; Suganthi C; Narayanan PR
    J Chemother; 2007 Apr; 19(2):166-71. PubMed ID: 17434825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.